key: cord-0294067-9twudyf3 authors: Stead, M.; Jessop, C.; Angus, K.; Bedford, H.; Ussher, M.; Ford, A.; Eadie, D.; MacGregor, A.; Hunt, K.; MacKintosh, A. M. title: A national survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications date: 2021-07-03 journal: nan DOI: 10.1101/2021.06.29.21259717 sha: 8055e64fa6c5e0ce06511e1d9410efe952daab57 doc_id: 294067 cord_uid: 9twudyf3 Background Hesitancy about COVID-19 vaccination threatens comprehensive vaccination. It is important to examine vaccination acceptance when people are making real rather than hypothetical decisions, to identify whether targeted support is needed, and to identify implications for communications. Methods Cross-sectional online and telephone survey with probability-based sample (n=4,978) of British adults, conducted January-February 2021. Measures: socio-demographic characteristics (age, gender, ethnicity, education, financial status), COVID-19 status, vaccine acceptance, trust in COVID-19 vaccination information sources, perceptions of vaccination priority groups, and perceptions of importance of second dose. Findings Among 5,931 individuals invited, survey response rate was 84%. COVID-19 vaccine acceptance (83%) was associated with increasing age, higher level of education and having been invited for vaccination. Acceptance decreased with unconfirmed past COVID-19, greater financial hardship, and non-White British ethnicity; Black/Black British participants had lowest acceptance. Overall, healthcare and scientific sources of information were most trusted. Compared with White British participants, other ethnicities had lower trust in healthcare and scientific sources. Those with lower educational attainment or financial hardship had lower trust in healthcare and scientific sources. Those with no qualifications had higher trust in media and family/friends. While trust was low overall in community or faith leaders it was higher among those with Asian/Asian British and Black/Black British ethnicity compared with White British participants. Views of vaccine prioritisation were mostly consistent with UK official policy but there was support for prioritising additional groups. There was high support for having the second vaccine dose. Conclusions Targeted engagement is needed to address COVID-19 vaccine hesitancy in non-White British ethnic groups, in younger adults, and among those with lower education, greater financial hardship and unconfirmed past infection. Healthcare professionals and scientific advisors should play a central role in communications and tailored messaging is needed for hesitant groups. Careful communication around vaccination prioritisation continues to be required. Background 25 Hesitancy about COVID-19 vaccination threatens comprehensive vaccination. It is important to 26 examine vaccination acceptance when people are making real rather than hypothetical decisions, to 27 identify whether targeted support is needed, and to identify implications for communications. 28 Cross-sectional online and telephone survey with probability-based sample (n=4,978) of British 30 adults, conducted January-February 2021. Measures: socio-demographic characteristics (age, 31 gender, ethnicity, education, financial status), COVID-19 status, vaccine acceptance, trust in 32 COVID-19 vaccination information sources, perceptions of vaccination priority groups, and 33 perceptions of importance of second dose. 34 Among 5,931 individuals invited, survey response rate was 84%. COVID-19 vaccine acceptance 36 (83%) was associated with increasing age, higher level of education and having been invited for 37 vaccination. Acceptance decreased with unconfirmed past COVID-19, greater financial hardship, 38 and non-White British ethnicity; Black/Black British participants had lowest acceptance. Overall, 39 healthcare and scientific sources of information were most trusted. Compared with White British 40 participants, other ethnicities had lower trust in healthcare and scientific sources. Those with lower 41 educational attainment or financial hardship had lower trust in healthcare and scientific sources. 42 Those with no qualifications had higher trust in media and family/friends. While trust was low overall 43 in community or faith leaders it was higher among those with Asian/Asian British and Black/Black 44 British ethnicity compared with White British participants. Views of vaccine prioritisation were mostly 45 consistent with UK official policy but there was support for prioritising additional groups. There was 46 high support for having the second vaccine dose. 47 Widespread vaccination is likely to be one of the most effective ways of controlling the COVID-19 60 pandemic, and is central to the UK government's recovery strategy. The UK vaccine programme 61 began in December 2020, prioritising older adults in care homes and their carers, those aged over 62 80, and frontline health and social-care workers [1] . Administration of first doses of vaccination to 63 the adult population, by decade of age, is to be completed by July 2021. Uncertainty or 64 unwillingness to accept vaccination -'vaccine hesitancy' [2]threatens comprehensive vaccination 65 [3, 4] . Before the introduction of a COVID-19 vaccine, UK surveys reported that 64% to 82% of 66 adults were willing to be vaccinated [5] [6] [7] [8] [9] [10] [11] [12] . Most of these studies used non-probability samples, 67 introducing selection bias and limiting generalisability. Increased vaccine confidence has been 68 reported since vaccination commenced [13] ; possibly due to increased COVID-19 cases and 69 deaths, a further UK lockdown in early 2021, and, increasingly, vaccination becoming the social 70 norm. It is important to examine vaccine acceptance when people are making active, rather than 71 hypothetical, decisions about vaccination. This also provides insight into potential acceptance of 72 repeat COVID-19 vaccination [14] . 73 74 UK uptake has been high (94% of adults surveyed in April reported uptake or intention to accept 75 vaccination) [13], but there remain concerns about uptake in subpopulations, such as younger 76 adults and some ethnic minorities [15] , giving rise to initiatives such as social media campaigns 77 featuring non-White celebrities [16] . Robust, timely data are needed to identify the characteristics of 78 groups with lower acceptance and the information sources they trust, to inform targeted 79 interventions. It is also important to assess whether attitudes towards COVID-19 vaccination have 80 been affected by specific events and media coverage. Two issues in the UK merit particular 81 attention. First, the government followed recommendations to offer the vaccine to priority groups [1] . 82 If this approach is continued, it is important to examine its acceptability and any implications for 83 communications. Secondly, the government decided, on 30 th December 2020, to deviate from 84 recommended protocols for the Pfizer-BioNTech vaccine by extending the interval between doses to 85 The survey was administered to the probability-based NatCen Panel [ Tables 1 and 2 . Age was categorised into bands from 18-29 years then ten-year 127 bands up to 80+. Self-assigned ethnicity was recorded in six categories, and education in five 128 categories according to highest qualification. As indices of multiple deprivation were not available, 129 self-reported financial status was used. COVID-19 status was derived from two items: 1) "Have you 130 officially been diagnosed with the coronavirus (COVID-19)?" (yes/no/don't know); those answering 131 other than 'yes' were asked: 2) "Do you think you have ever had the coronavirus (COVID-19)?" 132 (yes-definitely/yes-probably/no-probably not/no-definitely not/don't know). 133 134 Vaccine acceptance was derived from five items: 1) "Have you been offered a vaccine for COVID-136 19?" (yes/no). Those answering 'yes' were asked: 2) "And have you had that vaccine?" (yes/no). 137 Participants who had been offered but not yet had the vaccine were then asked: 3) "And do you 138 intend to have that vaccine?" (yes/no/not sure). Participants who had not yet been offered the 139 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. information about a COVID-19 vaccine from each of the following sources?" (see Table 3 ): 147 completely (1); a great deal (2); somewhat (3); very little (4); not at all (5). 148 Perceptions of vaccine priority groups were assessed across 11 groups (see Table 4 Descriptive data, including bivariate analyses, were weighted to be representative of British adult 161 population. Initial bivariate analyses, using chi-square tests, examined correlates of vaccine 162 acceptance and trust in sources of information about COVID-19 vaccination. Multivariate logistic 163 regression was conducted to examine differences in vaccine acceptance controlling for socio-164 demographic variables, vaccine offer, and COVID-19 status. The dependent variable dichotomised 165 those classed as accepted/intending to accept vs uncertain/refused/intend to refuse. Age was 166 entered as a categorical variable and the 'difference' contrast within SPSS logistic regression was 167 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint used to test influence of each increasing age group, relative to younger ages (e.g. 30-39 vs 18-29; 168 80+ vs 18-79) (see Table 2 ). Sociodemographic variation in trust in information sources was 169 examined using multivariate logistic regressions. For each information source, the dependent 170 The weighted sample comprised adults aged 18 and over (see Table 1 ). Over half (52%) were 181 female and 81% were White British. Around two-thirds reported 'living comfortably'/'doing alright', 182 while one in ten rated their financial status as 'quite' or 'very difficult'. Just over two-fifths were 183 educated to degree level or above, while for almost a quarter their highest qualification was A level 184 or equivalent. A minority (12%) had no qualifications. A minority indicated having been diagnosed 185 with COVID-19 (6%); nearly two-thirds thought they probably or definitely had not had COVID-19; 186 11% were unsure. 187 188 At the time of the survey, 14% (n=716) had been offered the vaccine. Of these, 92% (n=658) had 190 accepted or intended to, 4% (n=29) were uncertain, and 4% (n=29) had refused or intended to 191 refuse. 192 193 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. The three most trusted information sources were: the NHS; doctors/nurses/other healthcare 224 professionals; and scientific and medical advisers. These groups were trusted 'completely/a great 225 deal' by around 80% of participants (Table 3) . Only 44% trusted the UK government 'completely/a 226 great deal'. The three least trusted sources were celebrities and social media influencers, social 227 media, and faith or community leaders; around two-thirds indicated they would have no trust in 228 each. A majority (61%) indicated they had very little/no trust in the media (e.g. 229 newspapers/magazines/television/radio). 230 231 Trust did not differ by gender except for drug companies and the WHO, with females more likely to 232 indicate trust in these sources (Tables S5 and S9 respectively) . 233 Trust was higher among older participants for five sources (doctors/nurses/other healthcare 235 professionals, NHS, UK government, media, and family/friends; Tables S2, S4 , S6, S10, S13). For 236 example, trust in the UK government was higher among those aged 50-59 than 18-49-year-olds 237 (Table S6) . Tables S2-S6, S8, S9) . Similarly, participants from minority ethnic groups were less likely to trust 247 scientific or clinical sources than White British participants (Tables S2-S4 , S8, S9). Whilst lack of 248 trust in faith or community leaders was low overall, Asian/Asian British participants were more likely 249 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Nine in ten participants rated healthcare professionals as highest priority for vaccination. Over 70% 254 indicated those with serious health conditions/heightened vulnerability to COVID-19, care home 255 workers and residents, and over 80s should be 'one of the first' to be vaccinated (Table 4) . Priority 256 was also given to social care workers, schoolteachers, and those directly working with the public. 257 Over a third considered each of these groups should be 'one of the first' to be vaccinated, and 70% 258 or more rated them in the top two priority levels. People aged under 18 were rated as lowest priority, 259 and 6% considered the vaccine should not be offered to this group. Policy on a second dose and vaccination priority groups [1] was supported. 274 275 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint We confirmed lower acceptance in younger groups [6-8,10,11]; acceptance was higher if invited for (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint family/friends. This suggests a need for a mix of sources for these groups. Mainstream media may 303 have a role to play, despite lower trust [25] . 304 Reassuringly for further campaigns, prioritisation was considered acceptable and there was support 306 for additional prioritisation of schoolteachers and others in direct contact with the public. As planning 307 begins for further vaccination, careful communication regarding prioritisation should continue. We 308 found high support for a second dose, suggesting the UK's decision to extend the period between 309 doses has not dented public confidence. 310 311 Strengths include the large probability-based nationally representative sample, ability to analyse by 313 ethnicity and surveying during vaccine roll-out. Our findings can be generalised to GB's adult 314 population, however global contexts for COVID-19 and vaccination vary. Although not generalisable 315 to them, the findings are still informative for other countries. The study has limitations. As it is cross-316 sectional, we cannot infer causality; although we included variables likely to be important in vaccine 317 acceptance, these results are exploratory. Our qualitative studies will deepen understanding of 318 associations. A survey repeated when COVID-19 cases and deaths are low, and without lockdown, 319 might yield different responses. We did not survey individuals who are institutionalised (e.g. 320 prisoners), notably difficult to reach (e.g. homeless), or those not speaking English (therefore, our 321 ethnic minority sample may underrepresent certain views); specific surveys are needed for these 322 groups. We investigated vaccination intention. Actual uptake may be lower, although it is likely that 323 factors associated with intention will influence uptake. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint Diagnosed with COVID-19 241 4.8% 294 5.9% All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. # England and Wales, based on Office for National Statistics (ONS) definition of urban as population greater than 10,000. Scotland based on Scottish Government definition of urban as population greater than 3,000. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. After completion of the study, the survey dataset will be deposited in the UK Data Archive. The study received ethical approval from NatCen's Research Ethics Committee (ID P14307). Participants gave informed consent before taking part. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of UKRI. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259717 doi: medRxiv preprint Joint Committee on Vaccination and 338 Immunisation: advice on priority groups for COVID-19 vaccination Group on Vaccine Hesitancy. Vaccine hesitancy: definition, 343 scope and determinants Understanding vaccine hesitancy 345 around vaccines and vaccination from a global perspective: a systematic review of published 346 literature Vaccine hesitancy around the globe: analysis of 348 three years of WHO/UNICEF Joint Reporting Form data-2015-2017 Parents' and guardians' views on the 350 acceptability of a future COVID-19 vaccine: A multi-methods study in England COVID-19 vaccine 353 hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) Extended data fig. 1: 356 'If a COVID-19 vaccine is proven safe and effective and is available, I will take it'. In: A global survey 357 of potential acceptance of a COVID-19 vaccine Psychological 360 characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the 361 United Kingdom COVID-19 vaccine hesitancy in the UK household longitudinal study Attitudes towards vaccines and intention to vaccinate against 366 COVID-19: Implications for public health communications COVID-19 vaccination 369 intention in the UK: results from the COVID-19 Vaccination Acceptability Study (CoVAccS), a 370 nationally representative cross-sectional survey The Catalyst Project Team. Social 372 patterning and stability of intention to accept a COVID-19 vaccine in Scotland: will those most at risk 373 accept a vaccine? Coronavirus (COVID-19) latest insights Covid-19: Booster vaccine to be rolled out in autumn as UK secures 60m more 378 Pfizer doses Covid-19 vaccination hesitancy BAME groups urged to have Covid vaccine in UK TV ad campaign. The Guardian Revisiting the UK's strategy for 385 delaying the second dose of the Pfizer covid-19 vaccine Gallup. Ch 5 Attitudes to vaccines. In: Gallup. Wellcome Global Monitor. How does the world 393 feel about science and health? London: Wellcome Trust Cognitive Interviewing Practice The NatCen Panel: developing an open probability-based mixed-mode panel in Patient 401 reminder and recall interventions to improve immunization rates vaccine among adults at high-risk of COVID-19: a UK-wide survey Ethnic 407 differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit 408 admission, and death in 17 million adults in England: an observational cohort study using the 409 OpenSAFELY platform Coronavirus conspiracy suspicions, general 411 vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy 412 among UK residents during the COVID-19 pandemic Accelerated 415 vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants Assessment of protection 418 against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a 419 population-level observational study SARS-CoV-2 infection 421 rates of antibody-positive compared with antibody-negative health-care workers in England: a large multicentre, prospective cohort study (SIREN) Understanding COVID-424 19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving 425 citizens in Bradford Towards intervention 428 development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining 429 evidence-based and theoretically informed future intervention content No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity We thank the questionnaire development and testing and survey and data delivery teams at NatCen for their work on the survey, and Professor Mark Petticrew at the London School of Hygiene & Tropical Medicine for acting as adviser to the study.